Haleon plc(US:HLN)2026-02-25 08:02Financial Data and Key Metrics Changes - In 2025, the company achieved 3% organic sales growth, which is below the medium-term guidance of 4%-6% due to lower category growth and reduced consumer confidence in key markets [1][5] - Full year organic revenue growth was 3%, with a split of 2.3% from price and 0.7% from volume mix [11] - Gross margin improved by 220 basis points, resulting in 10.5% organic profit growth [6][10] - Free cash flow reached GBP 1.9 billion, with a reduction in working capital by 11 days [10][22] Business Line Data and Key Metrics Changes - Oral health grew by 7.9%, significantly outperforming the market, with strong growth in brands like Sensodyne and parodontax [13][20] - VMS (Vitamins, Minerals, and Supplements) grew by 1.9%, with strong performance outside the U.S. but impacted by a softer multivitamin category in North America [14] - OTC (Over-the-Counter) pain relief grew by 2.3%, with notable growth in Panadol and the launch of Voltaren patches [14][15] - Respiratory health declined by 1.9%, affected by a challenging consumer environment and a weaker cold and flu season [16] Market Data and Key Metrics Changes - North America experienced a 0.4% decline in organic revenue, with a split of 1% price increase and a 1.4% decline in volume mix [17] - EMEA and Latin America saw organic revenue increase by 4.7%, driven by price increases and resilient performance in oral health [19] - Asia Pacific reported a 5.2% organic revenue growth, with significant contributions from China and India [20] Company Strategy and Development Direction - The company is focused on three strategic priorities: delivering competitive growth, unlocking productivity gains, and embedding an agile culture [1][4] - Plans to evolve the operating model to drive growth and agility were announced, including the creation of new leadership roles and operating units [28][29] - The company aims to return North America to growth through targeted actions and investments in marketing and innovation [8][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in outperforming the market despite a challenging operating environment, with expectations for 2026 organic revenue growth in the range of 3%-5% [7][26] - The outlook for North America is cautiously optimistic, with plans to enhance market execution and innovation [7][32] - Management acknowledged the need for improved organic revenue performance and emphasized the focus on productivity to drive future growth [10][26] Other Important Information - The company allocated GBP 500 million for share buybacks in 2026 and proposed a final dividend of 4.9 pence, marking a 7.6% increase in total dividends for the year [6][25] - The new operating model is expected to deliver GBP 175 million-GBP 200 million in gross annualized savings, enhancing flexibility and agility [24] Q&A Session Summary Question: What are the expectations for organic revenue growth in 2026? - The company expects organic revenue growth to be in the range of 3%-5%, with a focus on returning North America to growth and continued strength in emerging markets [7][26] Question: How is the company addressing the challenges in North America? - The company is implementing a broader action plan, strengthening the North America team, and investing in capabilities to drive distribution and marketing effectiveness [32] Question: What are the key drivers of the productivity agenda? - Key drivers include reducing SKUs, optimizing supply chain efficiency, and leveraging automation and AI to enhance operational effectiveness [4][12]